Laboratory Facilities in Oxford s Life Sciences Cluster Officially Opened Labmate Online labmate-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labmate-online.com Daily Mail and Mail on Sunday newspapers.
Jun 29 2021
DJS Antibodies has announced its move into over 2,000 sqft of newly converted class II laboratory and office space at The Oxford Trust’s Wood Centre for Innovation, the second biotech to join alongside recent occupant Samsara Therapeutics.
Founded in 2015 by David Llewellyn and Joe Illingworth, who met at the University of Oxford’s Jenner Institute, DJS is working on therapeutics to treat critical inflammatory diseases that account for more than 50% of deaths worldwide. The lead programme of its HEPTAD antibody discovery platform targets a validated GPCR (G protein-coupled receptor) for the treatment of Diabetic Kidney Disease, a long-term condition that causes the irreversible loss of kidney function.